Arvinas Shares up 6.1% Co Enters Into Global License Agreement With Novartis for Prostate Cancer Drug
Arvinas股價上漲6.1%公司與諾華簽訂前列腺癌藥物全球許可協議
Arvinas Shares up 6.1% Co Enters Into Global License Agreement With Novartis for Prostate Cancer Drug
Arvinas股價上漲6.1%公司與諾華簽訂前列腺癌藥物全球許可協議
使用瀏覽器的分享功能,分享給你的好友吧